229 related articles for article (PubMed ID: 34173917)
1. Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.
Elfeki MA; Robles J; Akhtar Z; Ullah F; Ganapathiraju I; Tran C; Inman C; Collin SM; Rosa R
Dig Dis Sci; 2022 Jul; 67(7):3333-3339. PubMed ID: 34173917
[TBL] [Abstract][Full Text] [Related]
2. Advanced liver fibrosis and the metabolic syndrome in a primary care setting.
Schreiner AD; Zhang J; Durkalski-Mauldin V; Livingston S; Marsden J; Bian J; Mauldin PD; Moran WP; Rockey DC
Diabetes Metab Res Rev; 2021 Nov; 37(8):e3452. PubMed ID: 33759300
[TBL] [Abstract][Full Text] [Related]
3. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
Önnerhag K; Hartman H; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
[No Abstract] [Full Text] [Related]
5. Assessment of liver fibrosis using non-invasive screening tools in individuals with diabetes mellitus and metabolic syndrome.
Shaji N; Singhai A; Joshi R
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443467
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population.
Rigor J; Diegues A; Presa J; Barata P; Martins-Mendes D
Postgrad Med; 2022 May; 134(4):435-440. PubMed ID: 35332833
[TBL] [Abstract][Full Text] [Related]
7. Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19).
Lopez-Mendez I; Aquino-Matus J; Gall SM; Prieto-Nava JD; Juarez-Hernandez E; Uribe M; Castro-Narro G
Ann Hepatol; 2021; 20():100271. PubMed ID: 33099028
[TBL] [Abstract][Full Text] [Related]
8. Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease.
Prasoppokakorn T; Chan WK; Wong VW; Pitisuttithum P; Mahadeva S; Nik Mustapha NR; Wong GL; Leung HH; Sripongpun P; Treeprasertsuk S
World J Gastroenterol; 2022 Apr; 28(15):1563-1573. PubMed ID: 35582126
[TBL] [Abstract][Full Text] [Related]
9. Liver Fibrosis Marker and Postoperative Mortality in Patients Without Overt Liver Disease.
Zelber-Sagi S; O'Reilly-Shah VN; Fong C; Ivancovsky-Wajcman D; Reed MJ; Bentov I
Anesth Analg; 2022 Nov; 135(5):957-966. PubMed ID: 35417420
[TBL] [Abstract][Full Text] [Related]
10. Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index.
Tomeno W; Imajo K; Kuwada Y; Ogawa Y; Kikuchi M; Honda Y; Kato T; Kessoku T; Kirikoshi H; Yoneda M; Kitahora T; Saito S; Ozawa Y; Nakajima A
J Gastroenterol Hepatol; 2019 Aug; 34(8):1411-1416. PubMed ID: 30506860
[TBL] [Abstract][Full Text] [Related]
11. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran.
Amernia B; Moosavy SH; Banookh F; Zoghi G
BMC Gastroenterol; 2021 Dec; 21(1):453. PubMed ID: 34861841
[TBL] [Abstract][Full Text] [Related]
12. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications.
Ciardullo S; Muraca E; Perra S; Bianconi E; Zerbini F; Oltolini A; Cannistraci R; Parmeggiani P; Manzoni G; Gastaldelli A; Lattuada G; Perseghin G
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049637
[TBL] [Abstract][Full Text] [Related]
13. Hypertension and diabetes mellitus are associated with high FIB-4 index in a health checkup examination cohort without known liver disease.
Sato S; Kawai H; Sato S; Iwasaki H; Omori M; Kita Y; Ikeda Y; Awatsu T; Murata A; Taniguchi G; Shimada Y; Genda T
BMC Gastroenterol; 2022 Nov; 22(1):478. PubMed ID: 36411436
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.
Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW
J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932
[TBL] [Abstract][Full Text] [Related]
16. High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men.
Fujihara Y; Hamanoue N; Yano H; Tanabe M; Akehi Y; Nomiyama T; Yanase T
Endocr J; 2019 Jul; 66(7):637-645. PubMed ID: 31068503
[TBL] [Abstract][Full Text] [Related]
17. NAFLD and NASH are obesity-independent risk factors in COVID-19: Matched real-world results from the large PINC AI™ Healthcare Database.
Brozat JF; Ntanios F; Malhotra D; Dagenais S; Katchiuri N; Emir B; Tacke F
Liver Int; 2024 Mar; 44(3):715-722. PubMed ID: 38110709
[TBL] [Abstract][Full Text] [Related]
18. Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease.
Semmler G; Bachmayer S; Wernly S; Wernly B; Niederseer D; Huber-Schönauer U; Stickel F; Aigner E; Datz C
PLoS One; 2020; 15(12):e0244514. PubMed ID: 33382757
[TBL] [Abstract][Full Text] [Related]
19. The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004.
Li L; Huang Q; Yang L; Zhang R; Gao L; Han X; Ji L; Zou X
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334881
[TBL] [Abstract][Full Text] [Related]
20. Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups.
Sugiyama A; Kurisu A; E B; Ouoba S; Ko K; Rakhimov A; Akita T; Harakawa T; Sako T; Koshiyama M; Kumada T; Tanaka J
BMC Gastroenterol; 2022 May; 22(1):241. PubMed ID: 35562658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
